CRL vs ICLR: stock comparison and AI forecast
Charles River Laboratories International, Inc. (CRL) and Icon Plc (ICLR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CRL Charles River Laboratories International, Inc.
- Market Cap
- $16.16B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
ICLR Icon Plc
- Market Cap
- $15.83B
- P/E Ratio
- 52.6x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CRL and ICLR have similar market capitalizations ($16.16B and $15.83B).
- ICLR turns 3.7% of its revenue into net income, against -6.0% for CRL.
- CRL carries 1.64 times debt per unit of equity, against 0.78 times for ICLR.
- Both companies share the SEC industry classification Services-Commercial Physical & Biological Research.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CRL | ICLR |
|---|---|---|
| Market Cap | $16.16B | $15.83B |
| P/E Ratio | – | 52.60x |
| P/B Ratio | 5.69x | 1.73x |
| EPS | $-4.00 | $3.90 |
| Book Value/Share | $59.48 | $118.30 |
| Revenue/Share | $83.77 | – |
| FCF/Share | $7.76 | – |
Profitability & Margins
| Metric | CRL | ICLR |
|---|---|---|
| ROE | -8.4% | 3.3% |
| ROA | -3.2% | 1.9% |
| ROIC | 1.4% | 4.4% |
| Gross Margin | – | 24.5% |
| Operating Margin | 2.2% | 7.3% |
| Net Margin | -6.0% | 3.7% |
| EBT Margin | -0.9% | 6.2% |
| Tax Rate | -152.4% | 21.9% |
Financial Health
| Metric | CRL | ICLR |
|---|---|---|
| Current Ratio | 1.35x | 1.32x |
| Quick Ratio | 1.04x | – |
| D/E Ratio | 1.64x | 0.78x |
| Financial Leverage | 2.65x | 1.78x |
| Interest Coverage | 5.0x | 4.1x |
| Working Capital | $394M | $873M |
Cash Flow
| Metric | CRL | ICLR |
|---|---|---|
| Operating Cash Flow | $582M | $1.18B |
| Free Cash Flow | $371M | – |
| Capital Spending | -$212M | – |
| OCF Growth YoY | -26.1% | 2.2% |
| FCF Growth YoY | -35.9% | – |
| FCF/Sales | 9.3% | – |
| CapEx/Sales | 5.3% | – |
Operational Efficiency
| Metric | CRL | ICLR |
|---|---|---|
| Asset Turnover | 0.53x | – |
| Receivables Turnover | 5.6x | – |
| Fixed Assets Turnover | 2.7x | – |
| Days Sales Outstanding | 65 days | – |
| Payables Period | – | 5 days |
Income Statement
| Metric | CRL | ICLR |
|---|---|---|
| Total Revenue | $4.00B | – |
| Operating Income | $90M | $597M |
| Net Income | -$238M | $302M |
| SG&A Expense | $762M | $789M |
| Cost of Goods Sold | – | $6.16B |
Dividend & Shareholder Information
| Metric | CRL | ICLR |
|---|---|---|
| Shares Outstanding | 48M | 77M |
| Net Income Growth | – | -62.0% |
| EPS Growth | – | -59.9% |
CRL vs ICLR: stock comparison and AI forecast
Which is bigger, CRL or ICLR?
CRL and ICLR have similar market capitalizations ($16.16B and $15.83B).
Which one does Intratio's AI model rank higher, CRL or ICLR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.